BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8132626)

  • 1. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter.
    Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF
    J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional silencer of the Wilms' tumor gene WT1 contains an Alu repeat.
    Hewitt SM; Fraizer GC; Saunders GF
    J Biol Chem; 1995 Jul; 270(30):17908-12. PubMed ID: 7629096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
    Werner H; Roberts CT; Rauscher FJ; LeRoith D
    J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA-1 transactivates the WT1 hematopoietic specific enhancer.
    Wu Y; Fraizer GC; Saunders GF
    J Biol Chem; 1995 Mar; 270(11):5944-9. PubMed ID: 7890725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture.
    Scholz H; Bossone SA; Cohen HT; Akella U; Strauss WM; Sukhatme VP
    J Biol Chem; 1997 Dec; 272(52):32836-46. PubMed ID: 9407061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 is a critical regulator of the Wilms' tumor-1 gene.
    Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP
    J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the WT1 tumor suppressor gene promoter by Pea3.
    Discenza MT; Vaz D; Hassell JA; Pelletier J
    FEBS Lett; 2004 Feb; 560(1-3):183-91. PubMed ID: 14988020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation.
    Stanhope-Baker P; Williams BR
    J Biol Chem; 2000 Dec; 275(49):38139-50. PubMed ID: 10973960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1.
    Chen Y; Williams BR
    Gene Expr; 2000; 9(3):103-14. PubMed ID: 11243407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.
    Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D
    Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
    Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
    Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
    Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.